[HTML][HTML] Aneurysmal subarachnoid hemorrhage
S D'Souza - Journal of neurosurgical anesthesiology, 2015 - journals.lww.com
Aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden with high fatality
and permanent disability rates. The overall prognosis depends on the volume of the initial …
and permanent disability rates. The overall prognosis depends on the volume of the initial …
A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
Background Despite decades of research, cerebral vasospasm (CV) continues to account
for high morbidity and mortality in patients who survive their initial aneurysmal subarachnoid …
for high morbidity and mortality in patients who survive their initial aneurysmal subarachnoid …
Effects of clazosentan on cerebral vasospasm–related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in …
H Endo, Y Hagihara, N Kimura, K Takizawa… - Journal of …, 2022 - thejns.org
OBJECTIVE Clazosentan has been investigated globally for the prevention of cerebral
vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). The authors evaluated its …
vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). The authors evaluated its …
[HTML][HTML] Korean clinical practice guidelines for aneurysmal subarachnoid hemorrhage
WS Cho, JE Kim, SQ Park, JK Ko… - Journal of Korean …, 2018 - synapse.koreamed.org
Despite advancements in treating ruptured cerebral aneurysms, an aneurysmal
subarachnoid hemorrhage (aSAH) is still a grave cerebrovascular disease associated with a …
subarachnoid hemorrhage (aSAH) is still a grave cerebrovascular disease associated with a …
[HTML][HTML] The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral …
N Bruder, R Higashida, H Santin-Janin, C Dubois… - BMC neurology, 2022 - Springer
Background For patients presenting with an aneurysmal subarachnoid hemorrhage (aSAH),
delayed cerebral ischemia (DCI) is a significant cause of morbidity and mortality. The …
delayed cerebral ischemia (DCI) is a significant cause of morbidity and mortality. The …
Management of aneurysmal subarachnoid hemorrhage
N Etminan, RL Macdonald - Handbook of clinical neurology, 2017 - Elsevier
Spontaneous subarachnoid hemorrhage (SAH) affects people with a mean age of 55 years.
Although there are about 9/100 000 cases per year worldwide, the young age and high …
Although there are about 9/100 000 cases per year worldwide, the young age and high …
Cerebral vasospasm
CD Baggott, B Aagaard-Kienitz - Neurosurgery Clinics, 2014 - neurosurgery.theclinics.com
Vasospasm is defined as focal or diffuse temporarily narrowed vessel caliber due to
contraction of smooth muscle in the wall of arteries as detected by angiography or imaging …
contraction of smooth muscle in the wall of arteries as detected by angiography or imaging …
Delayed cerebral infarction is systematically associated with a cerebral vasospasm of large intracranial arteries
J Brami, B Chousterman, G Boulouis, M Le Dorze… - …, 2020 - journals.lww.com
BACKGROUND Whether delayed cerebral infarction (DCIn) after aneurysmal subarachnoid
hemorrhage (aSAH) is driven by large artery vasospasm is still controversial. OBJECTIVE To …
hemorrhage (aSAH) is driven by large artery vasospasm is still controversial. OBJECTIVE To …
[图书][B] Applied cerebral angiography: Normal anatomy and vascular pathology
GB Bradac - 2017 - books.google.com
This book offers detailed guidance on the diagnostic use of cerebral angiography based on
precise description of the angiographic appearances of normal anatomy and pathological …
precise description of the angiographic appearances of normal anatomy and pathological …
Clinical trial protocol: phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy, and safety study comparing EG-1962 to standard of …
D Hänggi, N Etminan, SA Mayer, EF Aldrich… - Neurocritical care, 2019 - Springer
Background Nimodipine is the only drug approved in the treatment of aneurysmal
subarachnoid hemorrhage (aSAH) in many countries. EG-1962, a product developed using …
subarachnoid hemorrhage (aSAH) in many countries. EG-1962, a product developed using …